/
CMND
$2.30-$0.08 (-3.36%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$3.5M
1M shares
52-week range
$2.04 – $524.00
0% from low
Exchange
NASDAQ
CS
Borrow rate
575.56%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-70797.70
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $2.5K | $119.6K | $57.4K | $51.1K | $49.4K |
| Gross profit | $0 | $0 | $0 | −$2.5K | −$119.6K | −$57.4K | −$51.1K | −$49.4K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $635.4K | $4.4M | $1.5M | $1.4M | $2.0M |
| Operating income | −$259.2K | −$104.1K | −$230.1K | −$3.6M | −$9.0M | −$6.3M | −$5.7M | −$5.7M |
| EBITDA | −$198.1K | −$104.1K | −$230.1K | −$3.7M | −$9.7M | −$8.5M | −$4.8M | −$3.7M |
| Net income | −$198.1K | −$104.1K | −$230.1K | −$3.7M | −$9.9M | −$8.6M | −$5.3M | −$3.9M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -73.50 | -33.76 | -50.76 | -473.10 | -916.44 | -170.07 | -6.78 | -3.03 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$1.00
Price
$2.30
Implied downside
-57%
Peer comparison
Clearmind Medicine Inc. Common Shares
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
www.clearmindmedicine.com- Employees
- 2
- IPO / List date
- Aug 10, 2021
Held by traders on TradeandTell
No one on the platform currently holds CMND.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CMND as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-05-21 | 1-for-10reverse |
| 2025-12-15 | 1-for-40reverse |
| 2023-11-28 | 1-for-30reverse |
| 2017-07-03 | 3.5-for-1 |
Recent trades on TradeandTell
No one on the platform has traded CMND yet.
